Inhibrx Biosciences, Inc. (NasdaqGS: INBX)
Health Care · Biotechnology · US
$90.54
-4.70% today · +171.5% 1Y
Inhibrx Biosciences, Inc. (NasdaqGS: INBX) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.40B and employs 110 people.
Over the last twelve months the share price has gained 171.5%, trading between 28.16 and 155.29.
Tweenvest scores Inhibrx Biosciences, Inc. across four factors: quality 26/100, value 57/100. Its strongest factor is value.
INBX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.40B
- Revenue (TTM)
- $0.00
- P/E
- —
- EPS
- -8.88
- Dividend yield
- —
- Beta (5Y)
- 3.82
- 52-week high
- $155.29
- 52-week low
- $28.16
- Avg volume (3M)
- —
- Shares outstanding
- 14.72M
- Employees
- 110
- Next earnings
- —
About Inhibrx Biosciences, Inc.
Inhibrx Biosciences, Inc. is a clinical-stage biopharmaceutical company, which includes a pipeline of novel biologic therapeutic candidates, developed using proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize multivalent formats where the precise valency can be optimized in a target-centric way to mediate what is believed to be the most appropriate agonist function. The company was founded by Brendan P. Eckelman on January 8, 2024 and is headquartered in La Jolla, CA.
- ISIN
- US45720N1037
- Founded
- 2024
- Listed since
- May 29, 2024
- Exchange
- Nasdaq Global Select
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Taysha Gene Therapies, Inc.NasdaqGS: TSHA | $1.46B | $4.17 | -7.24% |
| D&D Pharmatech Inc.KOSDAQ: A347850 | $1.46B | ₩42,850.00 | -0.35% |
| Bonesupport Holding AB (publ)OM: BONEX | $1.45B | Skr242.60 | +8.98% |
| Nektar TherapeuticsNasdaqCM: NKTR | $1.41B | $39.72 | -3.52% |
| Pacific Shuanglin Bio-pharmacy Co., Ltd.SZSE: 000403 | $1.39B | CN¥9.96 | -0.99% |
| AnaptysBio, Inc.NasdaqGS: ANAB | $1.37B | $46.08 | +0.28% |
| Tyra Biosciences, Inc.NasdaqGS: TYRA | $1.37B | $19.60 | -1.71% |
| Chongqing Genrix Biopharmaceutical Co., Ltd.SHSE: 688443 | $1.37B | CN¥24.95 | -1.38% |
Figures last refreshed Oct 11, 2026.